Author:
Scorsetti Marta,Comito Tiziana,Cozzi Luca,Clerici Elena,Tozzi Angelo,Franzese Ciro,Navarria Pierina,Fogliata Antonella,Tomatis Stefano,D’Agostino Giuseppo,Iftode Cristina,Mancosu Pietro,Ceriani Roberto,Torzilli Guido
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference35 articles.
1. Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radio-therapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81:e447–e453
2. Bibault JE, Dewas S, Vautravers-Dewas C et al (2013) Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity. PLoS One 8:e77472
3. Bujold A, Massey CA, Kim JJ et al (2012) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 44:1659
4. Cardenes HR, Price TR, Perkins SM et al (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12:218–225
5. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献